Labcorp Holdings LH Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Biopharma Laboratory Services | $3.1B+6.0% | $2.92B+5.3% | $2.77B+2.9% | $2.7B— | |
| Diagnostics | $10.88B+7.2% | $10.14B+7.7% | $9.42B+2.3% | $9.2B-11.2% | |
| Operating Income by Business | |||||
| Biopharma Laboratory Services | $498.5M+8.6% | $458.9M+15.8% | $396.3M+1.9% | $389.1M— | |
| Corporate Segment | -$482.2M+28.1% | -$670.8M-4.1% | -$644.1M-48.8% | -$432.8M-7.0% | |
| Diagnostics | $1.78B+10.8% | $1.61B+0.9% | $1.59B-21.4% | $2.03B-36.8% | |
| Other Cost and Expense, Operating by Business | |||||
| Biopharma Laboratory Services | $384.8M+4.5% | $368.1M-4.7% | $386.2M+9.1% | $353.9M— | |
| Diagnostics | $1.79B+10.0% | $1.63B— | —— | $1.38B— | |
| Accounts Receivable, before Allowance for Credit Loss by Business | |||||
| Biopharma Laboratory Services | $3.05B— | —— | —— | —— | |
| Diagnostics | $5.56B+7.5% | $5.18B+14.0% | $4.54B+5.1% | $4.32B— | |
| Labor and Related Expense by Business | |||||
| Biopharma Laboratory Services | $1.22B+4.8% | $1.17B+6.5% | $1.09B+2.3% | $1.07B— | |
| Diagnostics | $4.69B+5.6% | $4.44B+8.4% | $4.1B+11.9% | $3.66B— | |
| Supplies Expense by Business | |||||
| Biopharma Laboratory Services | $478.5M+8.3% | $441.9M-2.3% | $452.2M-1.8% | $460.6M— | |
| Diagnostics | $2.36B+6.7% | $2.21B+7.0% | $2.07B+7.9% | $1.91B— | |
| Depreciation by Business | |||||
| Biopharma Laboratory Services | $116M-5.4% | $122.6M+9.0% | $112.5M-0.3% | $112.8M— | |
| Diagnostics | $258.8M-0.1% | $259M+9.7% | $236.1M+4.0% | $227.1M-4.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Labcorp Holdings break its business down?
- Labcorp Holdings (LH) reports revenue by business across 2 parts — Biopharma Laboratory Services and Diagnostics. Each is extracted from the segment footnotes and tracked over time.
- Where does Labcorp Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Labcorp Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
